March 8, 2011
When heavily pregnant Danielle Crowley started having contractions every three minutes she was convinced she was going into labour five weeks early. But when she arrived at hospital blundering doctors and midwives checked her three times and dismissed her discomfort as kidney stones or back ache – as well as accusing the first-time mother-to-be of [...]
Read the full article →
March 8, 2011
Pfizer Inc. (NYSE:PFE) today announced that the ORAL Sync Phase 3 study (A3921046) of tofacitinib (development code: CP-690,550), formerly known as tasocitinib, an investigational, novel, oral JAK inhibitor, being studied in moderate-to-severe rheumatoid arthritis (RA), met its primary endpoints by showing statistically significant changes versus placebo in reducing signs and symptoms of RA, as measured [...]
Read the full article →